[Metabolic disorder of purine nucleotide in patients with chronic renal failure].
Hosoya
T
T
Second Department of Medicine, Jikei University School of Medicine.
Tabe
A
A
Hayashi
T
T
Sakai
O
O
D000493:Allopurinol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism*; D011685:Purine Nucleotides / Q000378:metabolism*; D006435:Renal Dialysis; D014511:Uremia / Q000209:etiology / Q000628:therapy; D014527:Uric Acid / Q000378:metabolism; D019820:Xanthine; D014970:Xanthines / Q000378:metabolism
D007042:Hypoxanthines; D011685:Purine Nucleotides; D014970:Xanthines; D019820:Xanthine; D014527:Uric Acid; D019271:Hypoxanthine; D000493:Allopurinol